Related Experiment Videos
[ T- and B-lymphocyte populations in thyroid pathology]
Problemy Endokrinologii
|January 1, 1980
Summary
Autoimmune thyroid disease involves T cell deficiency and excess B cells, while nontoxic goiter may show thyroid antibodies. Chemotherapy did not normalize immune function in diffuse toxic goiter patients.
Area of Science:
- Immunology
- Endocrinology
- Thyroid Research
Background:
- Thyroid pathology can significantly impact immune system function.
- Understanding immune cell dynamics is crucial for managing thyroid disorders.
- Autoimmune thyroid diseases are characterized by specific immune system alterations.
Purpose of the Study:
- To investigate cellular and humoral immunity in various thyroid pathologies.
- To assess immune responses in autoimmune thyroid disease, nontoxic goiter, and diffuse toxic goiter.
- To evaluate the impact of chemotherapy on immune indices in diffuse toxic goiter.
Main Methods:
- Analysis of cellular immunity, focusing on T and B lymphocytes.
- Assessment of humoral immunity, including circulating autoantibodies.
- Examination of patient blood samples across different thyroid condition groups.
Main Results:
- Autoimmune thyroid conditions showed T cell deficiency with B cell excess and antithyroid autoantibodies.
- Nontoxic goiter patients had normal lymphocyte counts but 40% exhibited thyroid autoantibodies.
- Early chemotherapy in diffuse toxic goiter did not restore normal cellular and humoral immunity.
Conclusions:
- Distinct immune profiles characterize different thyroid pathologies.
- Circulating autoantibodies are present in a significant portion of nontoxic goiter cases.
- Current chemotherapy regimens may not fully normalize immune function in diffuse toxic goiter.